• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以热休克蛋白90为靶点进行癌症治疗。

Targeting HSP90 for cancer therapy.

作者信息

Mahalingam D, Swords R, Carew J S, Nawrocki S T, Bhalla K, Giles F J

机构信息

Institute for Drug Development, Cancer Research and Therapy Centre at the University of Texas Health Science Centre, San Antonio, TX 78229, USA.

出版信息

Br J Cancer. 2009 May 19;100(10):1523-9. doi: 10.1038/sj.bjc.6605066. Epub 2009 Apr 28.

DOI:10.1038/sj.bjc.6605066
PMID:19401686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2696754/
Abstract

Heat-shock proteins (HSPs) are molecular chaperones that regulate protein folding to ensure correct conformation and translocation and to avoid protein aggregation. Heat-shock proteins are increased in many solid tumours and haematological malignancies. Many oncogenic proteins responsible for the transformation of cells to cancerous forms are client proteins of HSP90. Targeting HSP90 with chemical inhibitors would degrade these oncogenic proteins, and thus serve as useful anticancer agents. This review provides an overview of the HSP chaperone machinery and the structure and function of HSP90. We also highlight the key oncogenic proteins that are regulated by HSP90 and describe how inhibition of HSP90 could alter the activity of multiple signalling proteins, receptors and transcriptional factors implicated in carcinogenesis.

摘要

热休克蛋白(HSPs)是分子伴侣,可调节蛋白质折叠以确保正确的构象和转运,并避免蛋白质聚集。热休克蛋白在许多实体瘤和血液系统恶性肿瘤中表达增加。许多导致细胞转化为癌性形式的致癌蛋白是HSP90的客户蛋白。用化学抑制剂靶向HSP90会降解这些致癌蛋白,因此可作为有用的抗癌药物。本综述概述了HSP伴侣机制以及HSP90的结构和功能。我们还强调了受HSP90调节的关键致癌蛋白,并描述了抑制HSP90如何改变与致癌作用相关的多种信号蛋白、受体和转录因子的活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4abe/2696754/05b15c644d49/6605066f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4abe/2696754/05b15c644d49/6605066f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4abe/2696754/05b15c644d49/6605066f1.jpg

相似文献

1
Targeting HSP90 for cancer therapy.以热休克蛋白90为靶点进行癌症治疗。
Br J Cancer. 2009 May 19;100(10):1523-9. doi: 10.1038/sj.bjc.6605066. Epub 2009 Apr 28.
2
Heat Shock Protein 90 Inhibition in Cancer Drug Discovery: From Chemistry to Futural Clinical Applications.热休克蛋白90抑制在癌症药物研发中的应用:从化学到未来临床应用
Anticancer Agents Med Chem. 2016;16(3):280-90. doi: 10.2174/1871520615666150821093747.
3
Heat shock protein 90 inhibitors as therapeutic agents.热休克蛋白 90 抑制剂作为治疗药物。
Recent Pat Anticancer Drug Discov. 2012 Sep;7(3):313-36. doi: 10.2174/157489212801820066.
4
Targeting chaperones in transformed systems--a focus on Hsp90 and cancer.靶向转化系统中的分子伴侣——聚焦于热休克蛋白90与癌症
Expert Opin Ther Targets. 2006 Feb;10(1):37-50. doi: 10.1517/14728222.10.1.37.
5
The therapeutic target Hsp90 and cancer hallmarks.治疗靶点 Hsp90 与癌症特征。
Curr Pharm Des. 2013;19(3):347-65. doi: 10.2174/138161213804143725.
6
Heat shock proteins and cancer: How can nanomedicine be harnessed?热休克蛋白与癌症:纳米医学如何发挥作用?
J Control Release. 2017 Feb 28;248:133-143. doi: 10.1016/j.jconrel.2017.01.013. Epub 2017 Jan 11.
7
Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemia.热休克蛋白90——治疗人类急性髓系白血病的潜在靶点。
Curr Cancer Drug Targets. 2009 Sep;9(6):761-76. doi: 10.2174/156800909789271486.
8
Macrocyclic inhibitors of hsp90.大环抑制剂 hsp90。
Curr Top Med Chem. 2010;10(14):1380-402. doi: 10.2174/156802610792232088.
9
[Hsp90--a target for anticancer therapy].[热休克蛋白90——抗癌治疗的靶点]
Klin Onkol. 2011;24(5):329-37.
10
Inhibition of HSP90 molecular chaperones: moving into the clinic.抑制 HSP90 分子伴侣:走向临床。
Lancet Oncol. 2013 Aug;14(9):e358-69. doi: 10.1016/S1470-2045(13)70169-4.

引用本文的文献

1
HSP90 and the cancer transcriptome: a comprehensive review of inhibitors and mechanistic insights.热休克蛋白90与癌症转录组:抑制剂及机制见解的全面综述
Int J Clin Oncol. 2025 May 18. doi: 10.1007/s10147-025-02782-6.
2
Epichaperomes: redefining chaperone biology and therapeutic strategies in complex diseases.表观伴侣蛋白组:重新定义复杂疾病中的伴侣蛋白生物学及治疗策略
RSC Chem Biol. 2025 Mar 19;6(5):678-698. doi: 10.1039/d5cb00010f. eCollection 2025 May 8.
3
Synthesis, Anticancer Screening, and In Silico Evaluations of Thieno[2,3-]pyridine Derivatives as Hsp90 Inhibitors.

本文引用的文献

1
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis.对热休克蛋白70(HSC70)和热休克蛋白72(HSP72)的双重靶向作用可抑制热休克蛋白90(HSP90)的功能并诱导肿瘤特异性凋亡。
Cancer Cell. 2008 Sep 9;14(3):250-62. doi: 10.1016/j.ccr.2008.08.002.
2
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.热休克蛋白90(Hsp90)抑制可抑制突变型表皮生长因子受体(EGFR)-T790M信号传导并克服激酶抑制剂耐药性。
Cancer Res. 2008 Jul 15;68(14):5827-38. doi: 10.1158/0008-5472.CAN-07-5428.
3
The Hsp90 chaperone machinery.
噻吩并[2,3 - ]吡啶衍生物作为Hsp90抑制剂的合成、抗癌筛选及计算机模拟评估
Pharmaceuticals (Basel). 2025 Jan 24;18(2):153. doi: 10.3390/ph18020153.
4
Epichaperome Inhibition by PU-H71-Mediated Targeting of HSP90 Sensitizes Glioblastoma Cells to Alkylator-Induced DNA Damage.通过PU-H71介导的HSP90靶向抑制表观伴侣蛋白使胶质母细胞瘤细胞对烷化剂诱导的DNA损伤敏感。
Cancers (Basel). 2024 Nov 24;16(23):3934. doi: 10.3390/cancers16233934.
5
Functional and therapeutic significant of heat-shock protein 90 (HSP90) in reproductive cancers.热休克蛋白90(HSP90)在生殖系统癌症中的功能及治疗意义
Clin Transl Oncol. 2025 May;27(5):1933-1942. doi: 10.1007/s12094-024-03743-7. Epub 2024 Oct 6.
6
Rationally modified SNX-class Hsp90 inhibitors disrupt extracellular fibronectin assembly without intracellular Hsp90 activity.经过合理修饰的分选衔接蛋白(SNX)类Hsp90抑制剂可破坏细胞外纤连蛋白组装,而不影响细胞内Hsp90活性。
RSC Med Chem. 2024 Sep 2;15(10):3609-15. doi: 10.1039/d4md00501e.
7
Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies.热休克蛋白作为癌症的标志:从分子机制到治疗策略的见解。
J Hematol Oncol. 2024 Sep 4;17(1):81. doi: 10.1186/s13045-024-01601-1.
8
Bombinin-BO1 induces hepatocellular carcinoma cell-cycle arrest and apoptosis via the HSP90A-Cdc37-CDK1 axis.蛙皮素-BO1通过HSP90A-Cdc37-CDK1轴诱导肝癌细胞周期停滞和凋亡。
iScience. 2024 Jun 26;27(8):110382. doi: 10.1016/j.isci.2024.110382. eCollection 2024 Aug 16.
9
Molecular pathway of anticancer effect of next-generation HSP90 inhibitors XL-888 and Debio0932 in neuroblastoma cell line.下一代 HSP90 抑制剂 XL-888 和 Debio0932 在神经母细胞瘤细胞系中的抗癌作用的分子途径。
Med Oncol. 2024 Jul 3;41(8):194. doi: 10.1007/s12032-024-02428-z.
10
Identification and targeting of metastatic biomarkers for hepatocellular carcinoma therapeutics using small molecules library of curcumin analogues.利用姜黄素类似物小分子文库鉴定和靶向肝细胞癌治疗的转移生物标志物
Mol Divers. 2025 Feb;29(1):503-517. doi: 10.1007/s11030-024-10871-3. Epub 2024 Apr 30.
热休克蛋白90伴侣机制。
J Biol Chem. 2008 Jul 4;283(27):18473-7. doi: 10.1074/jbc.R800007200. Epub 2008 Apr 28.
4
Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor.通过用HSP90抑制剂和糖酵解抑制剂同时靶向缺氧癌细胞产生协同抗胰腺肿瘤作用。
Clin Cancer Res. 2008 Mar 15;14(6):1831-9. doi: 10.1158/1078-0432.CCR-07-1607.
5
Biology of HIF-1alpha.缺氧诱导因子-1α的生物学特性
Cell Death Differ. 2008 Apr;15(4):621-7. doi: 10.1038/cdd.2008.12. Epub 2008 Feb 15.
6
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.热休克蛋白抑制剂17-烯丙基氨基-17-去甲氧基格尔德霉素与卡铂联合应用于人类卵巢癌模型的体外和体内研究。
Cancer Chemother Pharmacol. 2008 Oct;62(5):769-78. doi: 10.1007/s00280-007-0662-x. Epub 2008 Jan 10.
7
Development and application of Hsp90 inhibitors.热休克蛋白90(Hsp90)抑制剂的研发与应用
Drug Discov Today. 2008 Jan;13(1-2):38-43. doi: 10.1016/j.drudis.2007.10.007. Epub 2007 Nov 26.
8
Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally.缺乏组蛋白脱乙酰基酶6的小鼠具有高度乙酰化的微管蛋白,但仍能存活且发育正常。
Mol Cell Biol. 2008 Mar;28(5):1688-701. doi: 10.1128/MCB.01154-06. Epub 2008 Jan 7.
9
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study.曲妥珠单抗与坦西莫司(17-AAG,KOS-953)联合应用于曲妥珠单抗难治性HER-2过表达乳腺癌患者安全且有效:一项I期剂量递增研究
J Clin Oncol. 2007 Dec 1;25(34):5410-7. doi: 10.1200/JCO.2007.11.7960.
10
PI3K/PTEN signaling in tumorigenesis and angiogenesis.PI3K/PTEN信号传导在肿瘤发生和血管生成中的作用
Biochim Biophys Acta. 2008 Jan;1784(1):150-8. doi: 10.1016/j.bbapap.2007.09.008. Epub 2007 Sep 29.